Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial

Full-dose prednisone (FP) regimen in the treatment of high-risk immunoglobulin A nephropathy (IgAN) patients, is still controversial. The pulsed intravenous methylprednisolone combined with alternative low-dose prednisone (MCALP) might have a more favorable safety profile, which has not been fully i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Fu, Rongguo, Gao, Jie, Wang, Li, Duan, Zhaoyang, Tian, Lifang, Ge, Heng, Ma, Xiaotao, Zhang, Yuzhan, Li, Ke, Xu, Peihao, Tian, Xuefei, Chen, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742122/
https://www.ncbi.nlm.nih.gov/pubmed/34996948
http://dx.doi.org/10.1038/s41598-021-03691-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742122/
https://www.ncbi.nlm.nih.gov/pubmed/34996948
http://dx.doi.org/10.1038/s41598-021-03691-0

Ejemplares similares